Table 1.
The characteristics of participants according to CAD.
Fig 1.
Flow chart for the enrollment of study population.
Fig 2.
The proportion of patients with CAD sorted by quartiles of PLR, NLR, MLR, SII.
PLR, platelet-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio; SII, the systemic immune inflammation index; CAD, coronary artery diseases; Q, quartiles.
Table 2.
Association of PLR, NLR, MLR, SII with the risk of CAD.
Table 3.
Association of PLR, NLR, MLR and SII with the risk of All-cause death.
Table 4.
Association of PLR, NLR, MLR and SII with the risk of Cardiovascular deaths.
Fig 3.
The Kaplan-Meier analysis of the prognostic effect of different levels of PLR, NLR, MLR and SII on all-cause mortality.
The unit of time was month. PLR, platelet-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio; SII, the systemic immune inflammation index.
Fig 4.
The Kaplan-Meier analysis of the prognostic effect of different levels of PLR, NLR, MLR and SII on cardiovascular mortality.
The unit of time was month. PLR, platelet-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio; SII, the systemic immune inflammation index.
Table 5.
The threshold effect of PLR, NLR, MLR and SII on CAD was analyzed using a two-stage phased regression model.
Fig 5.
(A) Association between PLR, NLR, MLR, SII and CAD; (B) Association between PLR, NLR, MLR, SII and all-cause mortality; (C) Association between PLR, NLR, MLR, SII and cardiovascular mortality; (a)PLR; (b)NLR; (c)MLR; (d) SII.
PLR, platelet-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio; SII, the systemic immune inflammation index; CAD, coronary artery diseases.
Table 6.
AUCs of four inflammation indexes for discriminating CAD.